What is the BGLC stock price prediction for next 2 weeks?

According to our price prediction algorithm,BioNexus Gene Lab Corp. (BGLC) price will be around $1.61 in the next 2 weeks. This means it will decrease by -7.241379310344821 from the last closing price. This prediction may vary from other time period filters for BGLC stock.

What can be the highest Possible price of BGLC stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, BGLC can achieve the highest price of $1.80 which is 3.661604645899774 higher than last closing price. This prediction may vary from other time period filters for BGLC stock.

What can be the lowest Possible price of BGLC stock in next 2 weeks?

As per the forecast and algorithmic analysis, BGLC stock price can be as low as $1.41 which is -18.821009518629474 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for BGLC stock.

Will BGLC stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that BGLC stock will lose-7.241379310344821 in the next 2 weeks. This prediction may vary from other time period filters for BGLC stock.

What is BGLC stock last closing price?

Last closing price of BGLC stock was $1.64.

What is BGLC stock price prediction?

BGLC stock price prediction means predicting the future closing prices of BGLC stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of BGLC stock in a certain time period.

How we predict BGLC stock future prices?

If you are searching for BGLC stock forecast, analysis or price prediction, then you might be wondering what BioNexus Gene Lab Corp. (BGLC) will do in the future. Our BGLC price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This BGLC price prediction will likely answer most of your questions.

How frequent we update BGLC stock predictions?

We are updating the forecasts for the BGLC stock on daily basis.

Is using ML forecasting for BGLC stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for BGLC stock same for all the time periods?

No, the prediction for BGLC stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

BioNexus Gene Lab Corp. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$1.64-15.9%Since 2 Weeks

Predicted Price$1.61-7.24%For 2 Weeks

Upper Predicted Price$1.803.66%For 2 Weeks

Lower Predicted Price$1.41-18.82%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of BGLC will decline by -7.24% over the next 2 Weeks and hit $1.61 by Monday, July 27, 2026. In that time frame, BGLC's share price is expected to range between $1.41 and $1.80.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jul 28, 2026	1.28	1.46	1.66
Jul 27, 2026	1.33	1.53	1.72
Jul 24, 2026	1.20	1.41	1.61
Jul 23, 2026	1.28	1.49	1.69
Jul 22, 2026	1.29	1.50	1.68
Jul 21, 2026	1.34	1.56	1.75
Jul 20, 2026	1.44	1.63	1.82
Jul 17, 2026	1.33	1.51	1.72
Jul 16, 2026	1.40	1.59	1.78
Jul 15, 2026	1.39	1.60	1.78

BGLC shares fell -5.75% in Tuesday, July 14, 2026's trading session, dropping from a previous close of $1.74 to move at $1.64. The stock demonstrated notable intraday movement (see BGLC's key stats for a full breakdown), fluctuating between $1.55 and $1.75, a +12.90% trading range. While recent weeks have seen some volatility, BGLC has managed to secure a -15.90% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 6.94K shares changing hands, 2.82K more than the previous session. This amounted to $11.38K in total market activity.

Will BGLC Continue Its Upward Trend?

According to analyst ratings and projections for BGLC, BioNexus Gene Lab Corp. shares are anticipated to increase by +1.36%, potentially reaching $1.66 per share by July 28, 2026. Short-term technical indicators currently suggest a neutral sentiment for BGLC. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the BGLC stock forecast, now is a good time to buy BGLC stock because its current trading price is +12.53% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BGLC covering social and institutional perspectives.

BGLC Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into BGLC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 28.72% to 36.68%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 41.38%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.69%, maintains a neutral outlook for the long term. Insights into BGLC's shareholder base show how institutional investors are positioning themselves during these momentum shifts

BioNexus Gene Lab Short-Term Forecasts

BGLC Forecast For Next 5 Days

Our algorithm anticipates BioNexus Gene Lab (BGLC) stock could hit $1.82 by Jul 21, 2026. This represents a +11.23% fall from today's price, following a -11.73% change over the past five days.

BGLC Forecast For Next 30 Days

Based on analysis of market trends, the outlook for BioNexus Gene Lab Corp. (BGLC) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $1.86, which would mean a +13.41% increase from the current price of $1.64. Projections for this period range from a high of $2.26 to a low of $1.54.

BGLC Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for BioNexus Gene Lab's price over the next three months point to a drop. BGLC stock is expected to peak at $3.70 on Jul 15, 2026 before potentially dipping to $0.00 on Oct 14, 2026. On average, BGLC is likely to trade around $0.19 in the coming 90 days.

BioNexus Gene Lab Stock Forecast 2025

Based on our predictive models, BioNexus Gene Lab (BGLC) is expected to trade between $0.00 and $4.13 throughout 2026. This would result in an average price of $0.21, potentially offering investors a -87.20% return from current levels.

BioNexus Gene Lab Corp. Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, BioNexus Gene Lab Corp. (BGLC) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $3.70, settling at an average of $0.72. This could translate to a -56.10% loss.

August 2026

Based on current market signals, BioNexus Gene Lab Corp. is projected to trend august 2026. We forecast a trading range from $0.00 to $1.99, with a likely average price of $0.02. Investors could expect a potential return of -98.78%.

September 2026

Our predictive algorithms indicate BioNexus Gene Lab Corp. stock may see a shift in September 2026. The expected range spans $0.00–$2.42, with an average target of $0.03. This represents a cautious outlook and a possible loss of -98.17%.

October 2026

Analyzing established trends, BioNexus Gene Lab Corp. looks set to move in October 2026. Projections place the stock between $0.00 and $4.13, averaging around $0.64. This suggests a -60.98% loss from current levels.

November 2026

Market indicators suggest BioNexus Gene Lab Corp. could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $2.59, with a midpoint forecast of $0.07. The stock might deliver a -95.73% loss.

December 2026

Forecasting for December 2026, models estimate that BioNexus Gene Lab Corp. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.80, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.

January 2027

According to our latest forecast models, BioNexus Gene Lab Corp. (BGLC) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.00 and $2.34, settling at an average of $0.13. This could translate to a -92.07% loss.

February 2027

Based on current market signals, BioNexus Gene Lab Corp. is projected to trend february 2027. We forecast a trading range from $0.00 to $2.53, with a likely average price of $0.12. Investors could expect a potential return of -92.68%.

March 2027

Our predictive algorithms indicate BioNexus Gene Lab Corp. stock may see a shift in March 2027. The expected range spans $0.00–$4.78, with an average target of $1.17. This represents a cautious outlook and a possible loss of -28.66%.

April 2027

Analyzing established trends, BioNexus Gene Lab Corp. looks set to move in April 2027. Projections place the stock between $0.00 and $2.99, averaging around $0.14. This suggests a -91.46% loss from current levels.

May 2027

Market indicators suggest BioNexus Gene Lab Corp. could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $1.11, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.

June 2027

Forecasting for June 2027, models estimate that BioNexus Gene Lab Corp. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.39, averaging $0.04. This signals a cautious trajectory with potential returns around -97.56%.

July 2027

According to our latest forecast models, BioNexus Gene Lab Corp. (BGLC) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $2.90, settling at an average of $0.64. This could translate to a -60.98% loss.

BGLC's history of dividends and stock splits also plays a role in long-term investor confidence.